Skip to content
The Nexus
DossierENTITY

pharmaceutical supply chain

Coverage of pharmaceutical supply chain in the Nexus archive.

Earliest in view: Apr 22 · 00:41 UTCMost recent: Jun 29 · 19:34 UTC
Co-mentioned in this coverage
FDAorganization1Eli Lillyorganization1Regeneronorganization1CNBCorganization1Iranplace1Strait of Hormuzplace1CBS Newsorganization1Dr. Céline Gounderperson1
Recent coverage
  • HEALTHJun 29 · 19:34 UTCBATON ROUGE BUSINESS REPORT
    A new FDA strategy aims to get medicines to the market faster

    The FDA has launched a pilot program with Eli Lilly and Regeneron to accelerate the development and approval of U.S. drug manufacturing facilities by engaging companies during design and construction phases. The initiative aims to reduce delays, improve compliance, and strengthen the domestic pharmaceutical supply chain to reduce reliance on overseas production.

  • HEALTHApr 22 · 00:41 UTCCBS NEWS
    What medications are at risk as Strait of Hormuz blockade threatens supply chain

    The war with Iran has disrupted the Strait of Hormuz, a critical global shipping lane, threatening the pharmaceutical supply chain. Medications are at risk as the blockade impacts transportation routes, according to CBS News medical contributor Dr. Céline Gounder.